Tissue processing method |
| I claim: 1. A method of processing a tissue specimen, comprising the steps of suspending the ... |
|
Radioactive scanning agents with stabilizer |
| OF THE INVENTION This invention is based on the discovery that gentisyl alcohol and its phenolate ... |
|
Homocysteine thiolactone perchlorate as a tumor promotor |
| I claim: 1. A method of promoting the growth of malignant tumors in laboratory animals such as mice ... |
|
Time-release |
| We claim: 1. A tablet or dragee core for a time-release pharmaceutical composition, suitable for ... |
|
Process for the production of a sensitive plate for an exoelectron dosimeter |
| The present invention relates to a process for carrying out the deposition of the mixture of the ... |
|
Working up of the residual gases resulting from the production of cyanuric chloride |
| What is claimed is: 1. A process for working up the chlorine containing residual gases obtained in ... |
|
Aqueous coating composition from a mercaptan containing polymer and a bis-maleimide |
| OF THE INVENTION The coating composition contains a polymer or resin selected according to final ... |
|
Erasable ball-point pen ink |
| OF THE INVENTION The excellent writing performance described hereinbefore and hereinafter implies ... |
|
Automatic enzyme immunoassay apparatus |
| It is therefore an object of the present invention to provide an automatic enzyme immunoassay ... |
|
|
Treatment of neurotransmitter-linked drug abuse
| Details |
Inventors: Golwyn, Daniel H.;
Assignee:
Primary Examiner: Wax; Robert A.
Assistant Examiner:
Attorney, Agent or Firm: McClure; Charles A.
Treatment of the abuse of those addictive drugs whose apparent mode of operation includes first an enhancement of neurotransmitter activity and subsequently a reduction in that activity--and in accompanying pleasurable sensations--to such an extent that abusers thereof feel compelled to repeat the experience. Examples of abused drugs for which treatment is suitable are amphetamines, cocaine, meperidine, phencyclidine, and new "designer" drugs. The treatment is by daily dosage of phenelzine or equivalent phenylalkylhydrazine so as to effect a degree of monoamine oxidase inhibition incompatible with the abused drug during the period of treatment and for at least a couple weeks thereafter. Concurrent usage is productive of a broad range of dangerous and frightening reactions, described in graphic detail to all patients undergoing such treatment, and any breach of the prohibition confirms the necessity of remaining free of the abused drug throughout. The treatment is effective in producing at least temporary and frequently longer-lasting abstinence. |
|
DETAILED DESCRIPTION OF THE INVENTION The Biel patent describes numerous phenylalkylhydrazines, their preparation, and uses. Their principal suggested use is as psychotherapeutics, specifically as inhibitors of the natural metabolic conversion or destruction of neurotransmitters in the brain by monoamine oxidase (MAO). Such inhibitory activity, or MAOI, is considered to be anti-depressant, inasmuch as depletion of neurotransmitters may interfere with a customary sense of well being sufficiently to give rise to a feeling of depression. MAOI is conducive to assertiveness, motivation, and self-confidence and to reducing anxiety, indecisiveness, perfectionism, and phobias. Biel notes especially as "most potent" the MAOI activity of phenylalkylhydrazines with up to three carbon atoms in the straight portion of the hydrocarbon chain between the phenyl group and the substituted hydrazine residue, viz. , the phenylethyl, phenylpropyl, and phenylbutyl hydrazines, including those with branched (iso-) or normal (n-) chains, and also those with possible substituents, such as lower alkyl, lower alkoxy, or halogen in the phenyl group. Biel indicates clinical improvement from administration of a specifically chosen phenylalkylhydrazine as evidenced by alertness, elevation of mood, and diminution of confusion, and by reduction in depressive attitudes. He singles out phenylisopropylhydrazine or, more technically, N-(3-phenyl-2-propyl)-hydrazine as an example. Also singled out by Biel for special recommendation are a half dozen additional single-N-substituted phenylalkylhydrazines: (3-p-methoxyphenyl-2-propyl)-hydrazine, (3-o-methylphenyl-2-propyl)-hydrazine, [3(3',4'-methylenedioxy)-phenyl-2-propyl]-hydrazine, (2-phenyl-1-propyl)-hydrazine, (4-phenyl-2-butyl)-hydrazine, and (3-m-chlorophenyl-2-propyl)-hydrazine. Example 5 of the patent is drawn to production of phenylisopropylhydrazine; whereas Example 6 is drawn to its hydrochloride salt. Examples 1 and 2 are similarly devoted to phenelzine (2-phenethyl)hydrazine and its similar salt
|
| Related patents |
|
|
Method of treating cognitive and related neural behavioral problems
OF THE INVENTION The novel compounds of the invention are in general obtainable as white, yellow or tan crystalline solids having characteristic melting points and ...
|
|
|
Quinoline derivatives as antagonists of leukotriene D.sub.4
We claim: 1. A compound of the formula ##STR15## where: A is O or S; D is O, S, NR.sub.1, ##STR16## or a chemical bond E is a chemical bond or ##STR17## a is 0-2; b is 0-...
|
|
|
Immobilization of enzymes on human tissue or erythrocytes
I claim: 1. A method for immobilizing an enzyme on tissue or erythrocytes comprising the steps of reacting the enzyme having nucleophilic groups selected from the group ...
|
|
|
Free-flowing, high density, agglomerated vitamin A powder compositions
OF THE INVENTION Free-flowing high density agglomerates suitable for direct compression into tablets, prepared by the process of this invention, i.e., the introduction ...
|
|
|
Spray dried vitamin E powder
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A vitamin E powder suitable for the preparation of ...
|
|
|
Dry stabilized microemulsified omega-three acid-containing oils
The marine animal oil to be microemulsified may be derived from any desired marine animal source. Among the marine animal oils particularly contemplated for use are ...
|
|
|
Anti-ulcer composition
OF THE INVENTION The present invention provides an improved composition for ulcer curative/ulcer therapy agents capable of forming an ulcer-adherent protective complex, ...
|
|
|
Pediatric effervescent dosage form
OF THE PREFERRED EMBODIMENT An oral dosage form according to one embodiment of the present invention is a tablet of a size and shape adapted for direct oral ...
|
|
|
Defoaming composition
OF THE INVENTION The preferred fluid, nonaqueous, antifoaming or defoaming compound prepared as a flowable granule used herein is simethicone and, more specifically, ...
|
|
|
Fire-resistant styrene polymer foams
OF THE INVENTION In accordance with the invention, a variety of expandable thermoplastic homopolymers and copolymers can be made to have reduced flammability. The ...
|
|
|